Inactive Instrument
Abpro Corporation Share Price Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 13.45L 11.68L 10.89L 10L 18.92L 13Cr 19.13L 1.28Cr 50.18L 6.4Cr 50.51L 49.4L 21Cr | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 14.25L 12.37L 11.54L 10.6L 20.04L 14Cr 20.26L 1.36Cr 53.17L 6.78Cr 53.51L 52.34L 22Cr | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 13.45L | |
| +0.32% | -2.99% | 0.00% | +13.75% | 4.8TCr | |
| +1.75% | +8.70% | +412.28% | +563.51% | 4.11TCr | |
| +3.00% | -5.06% | +27.78% | +7.17% | 3.76TCr | |
| +2.24% | +0.61% | +7.15% | +75.55% | 3.59TCr | |
| +1.98% | +4.74% | +12.19% | +41.37% | 2.99TCr | |
| +0.85% | -1.84% | - | - | 1.61TCr | |
| +1.51% | -0.06% | +33.98% | +124.49% | 1.61TCr | |
| +1.22% | +1.40% | +4.50% | +18.53% | 1.38TCr | |
| +4.72% | -7.44% | -0.63% | -34.44% | 1.21TCr | |
| Average | +1.78% | -1.81% | +62.16% | +101.24% | 2.78TCr | |
| Weighted average by Cap. | +1.85% | -0.93% | +82.01% | +127.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2L 2L 1L 1L 3L 1.74Cr 3L 17.47L 7L 87.02L 7L 7L 2.88Cr | - |
| Net income | -72.32L -62.8L -58.55L -53.79L -1.02Cr -69Cr -1.03Cr -6.9Cr -2.7Cr -34Cr -2.72Cr -2.66Cr -113.94Cr | -28.92L -25.11L -23.41L -21.51L -40.68L -28Cr -41.12L -2.76Cr -1.08Cr -14Cr -1.09Cr -1.06Cr -46Cr |
| Net Debt | 5L 4L 4L 4L 7L 4.55Cr 7L 45.62L 17.84L 2.27Cr 17.95L 17.56L 7.53Cr | 80T 69.46T 64.77T 59.5T 1L 76.1L 1L 8L 3L 38.04L 3L 3L 1.26Cr |
Employees
-
